159 related articles for article (PubMed ID: 3469153)
1. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Chau PY; Leung YK; Ng WW
Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
3. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of T-3761, a new fluoroquinolone.
Muratani T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
Espinoza AM; Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):663-70. PubMed ID: 3293524
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of fleroxacin, two other quinolones and three board-spectrum beta-lactams using the E-Test.
Sobottka I; Neumann S; Laufs R
Chemotherapy; 1994; 40(5):293-8. PubMed ID: 7956451
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
8. In-vitro selection of bacteria resistant to the 4-quinolone agents.
Limb DI; Dabbs DJ; Spencer RC
J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Digranes A
Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):29-32. PubMed ID: 3105246
[TBL] [Abstract][Full Text] [Related]
11. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
Cunha BA; Qadri SM; Ueno Y; Walters EA; Domenico P
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067
[TBL] [Abstract][Full Text] [Related]
13. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Matsuzaki K; Watabe E; Yoshimori K; Shikano M; Sato Y; Hasegawa M; Kobayashi I
Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.
Di Modugno E; Broggio R; Erbetti I; Lowther J
Antimicrob Agents Chemother; 1997 Dec; 41(12):2742-8. PubMed ID: 9420050
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Pelak BA; Bartizal K; Woods GL; Gesser RM; Motyl M
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):129-33. PubMed ID: 12088620
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
18. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of amifloxacin (WIN 49, 375), a new quinolone agent.
Neu HC; Labthavikul P
Diagn Microbiol Infect Dis; 1985 Nov; 3(6):469-78. PubMed ID: 4064609
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activity of a new fluorinated 4-quinolone, QA-241.
Niu WW; Neu HC
Diagn Microbiol Infect Dis; 1989; 12(3):243-51. PubMed ID: 2791486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
